MedTrace Logo

Phase 1 Clinical Trial of CordSTEM-ST

NCT06578039 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2025-11-19

No results posted yet for this study

Summary

This clinical study will evaluate the safety and tolerability of CordSTEM-ST after administering a single dose in patients with premature ovarian insufficiency (POI), as well as identify the maximum tolerated dose (MTD) and evaluate the potential therapeutic effects.

Conditions

  • Premature Ovarian Insufficiency

Interventions

BIOLOGICAL

umbilical cord-derived mesenchymal stem cell

allogeneic umbilical cord-derived mesenchymal stem cell

Sponsors & Collaborators

  • CHABiotech CO., Ltd

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
25 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-30
Primary Completion
2025-04-28
Completion
2025-04-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06578039 on ClinicalTrials.gov